New patent for Eli Lilly drug OLUMIANT

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for OLUMIANT
Annual Drug Patent Expirations for OLUMIANT

Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

Drug patent litigation for OLUMIANT.

This drug has eigthy-nine patent family members in forty-four countries.

The generic ingredient in OLUMIANT is baricitinib. One supplier is listed for this compound. Additional details are available on the baricitinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top